242452-35-3

Usage

Uses

Used in Pharmaceutical Industry:
1-(4-(AMinoMethyl)phenyl)-N,N-diMethylMethanaMine hydrochloride is used as an antidepressant medication for treating mental health conditions such as depression, obsessive-compulsive disorder, and anxiety disorders. It helps restore the balance of serotonin in the brain, leading to an improvement in mood, appetite, and energy levels.
Used in Mental Health Treatment:
1-(4-(AMinoMethyl)phenyl)-N,N-diMethylMethanaMine hydrochloride is used as a therapeutic agent for managing the symptoms of mental health disorders. It is typically taken orally in the form of a tablet or liquid solution and should be used under the guidance of a healthcare professional to ensure proper dosage and monitoring of side effects, which may include nausea, headaches, and dizziness.

Upstream product

• 17201-43-3 4-cyanobenzyl bromide 
• 35525-86-1 4-cyano-N,N-dimethylbenzylamine 

Downstream Products

• 252956-43-7 C₁₇H₂₁ClN₂ 
• 1456890-17-7 N-{4-[(dimethylamino)methyl]benzyl}-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-5-carboxamide 

Relevant academic research and scientific papers

ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATORS, THEIR DERIVATIVES AND USES THEREOF

The present application is related to compounds represented by Formula I, which are novel positive allosteric modulators of α7 nAChRs. The application also discloses the treatment of disorders that are responsive to enhancement of acetylcholine action on α7 nAChRs in a mammal by administering an effective amount of a compound of Formula I.

NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION

Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, multimers, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.

Non-peptide GnRH agents, methods and intermediates for their preparation

Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, multimers, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.